TrialAntimicrobial agents and chemotherapy2015

Evaluation of Daptomycin Exposure and Efficacy and Safety Endpoints To Support Risk-versus-Benefit Considerations.

Sujata M Bhavnani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.